Tyler A. Longmire

Efficient Derivation of Purified Lung and Thyroid Progenitors from Embryonic Stem Cells

Tyler A. Longmire, Laertis Ikonomou, Finn Hawkins et al. · Cell stem cell · 2012 · 387 citations · Full text

Embryonic Stem Cell, Induced Pluripotent Stem Cell, Purified Lung +12

Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors

Giuseppe Curigliano, Hans Gelderblom, Nicolas Mach et al. · Clinical Cancer Research · 2021 · 335 citations · Full text

Excision of Reprogramming Transgenes Improves the Differentiation Potential of iPS Cells Generated with a Single Excisable Vector  

Cesar Sommer, Andreia Gianotti Sommer, Tyler A. Longmire et al. · Stem Cells · 2009 · 268 citations · Full text

Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies

Patrick Schöffski, Daniel Shao-Weng Tan, Miguel Martín et al. · Journal for ImmunoTherapy of Cancer · 2022 · 147 citations · Full text

Phase Ib Study of the Anti-TIM-3 Antibody MBG453 in Combination with Decitabine in Patients with High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Uma Borate, Jordi Esteve, Kimmo Porkka et al. · Blood · 2019 · 85 citations